Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival

類似資料

• Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
  著者:: Ezgi Ozyerli-Goknar, 等
  出版事項: (2023-11-01)
• EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities
  著者:: Yedier-Bayram, O, 等
  出版事項: (2022)
• The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma
  著者:: Ozyerli-Goknar, E, 等
  出版事項: (2019)
• Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
  著者:: Saraç, H, 等
  出版事項: (2019)
• Homeotic shift at the dawn of the turtle evolution
  著者:: Tomasz Szczygielski
  出版事項: (2017-01-01)